×
About 3,275 results

ALLMedicine™ Cardioversion Center

Research & Reviews  1,033 results

Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients betw...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101720
International Journal of Environmental Research and Publi... Gorczyca-Głowacka I, Bielecka B et. al.

May 15th, 2022 - In the recent years, antithrombotic prophylaxis in patients with atrial fibrillation (AF) has changed significantly. The main aim of this study is to assess the temporal trends of antithrombotic therapy and identify factors predisposing oral antic...

PVI Alone or in Combination wIth Substrate Modulation aFter electrIc Cardioversion Failure
https://clinicaltrials.gov/ct2/show/NCT05264831

May 6th, 2022 - Atrial fibrillation (AF) is the most common heart rhythm disorder. It is the result of uncoordinated action of the atrial myocardial cells, causing rapid and irregular contraction of the heart's atria. The AF prevalence in adults is currently esti...

Associations between blood biomarkers, cardiac function and adverse outcome in a young ...
https://doi.org/10.1016/j.ijcard.2022.04.065
International Journal of Cardiology; van den Bosch E, van Genuchten WJ et. al.

Apr 30th, 2022 - To determine the potential prognostic value and clinical correlations of blood biomarkers in a cohort of patients with Tetralogy of Fallot (TOF). In the setting of multicenter prospective research studies TOF patients underwent blood sampling, car...

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
https://clinicaltrials.gov/ct2/show/NCT05039359

Apr 28th, 2022 - This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled clinical study designed to evaluate the efficacy and safety of FlecIH-103 (flecainide acetate inhalation solution) compared with placebo in patients with recent-onset, sy...

Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025387
International Journal of Environmental Research and Publi... Ceynowa-Sielawko B, Wybraniec MT et. al.

Apr 24th, 2022 - Pharmacological cardioversion (PCV) is commonly a primary option for termination of recent-onset atrial fibrillation (AF) in emergency departments (ED). This is a subanalysis of the CANT II study, evaluating the effectiveness and safety of antazol...

see more →

Guidelines  4 results

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Managemen...
https://doi.org/10.1016/j.cjca.2018.08.026
The Canadian Journal of Cardiology; Andrade JG, Verma A et. al.

Nov 9th, 2018 - The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in atrial fibrillation (AF) management. This 2018 Focuse...

2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A R...
https://doi.org/10.1161/HAE.0000000000000014
Circulation. Arrhythmia and Electrophysiology; Zipes DP, Calkins H et. al.

Sep 20th, 2015 - 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion).|2015|Zipes...

Parenteral anticoagulants in heart disease: current status and perspectives (Section II...
https://doi.org/10.1160/TH12-06-0403
Thrombosis and Haemostasis; De Caterina R, Husted S et. al.

May 3rd, 2013 - Anticoagulants are a mainstay of cardiovascular therapy, and parenteral anticoagulants have widespread use in cardiology, especially in acute situations. Parenteral anticoagulants include unfractionated heparin, low-molecular-weight heparins, the ...

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stro...
https://doi.org/10.1016/j.cjca.2010.11.007
The Canadian Journal of Cardiology; Cairns JA, Connolly S et. al.

Feb 19th, 2011 - The stroke rate in atrial fibrillation is 4.5% per year, with death or permanent disability in over half. The risk of stroke varies from under 1% to over 20% per year, related to the risk factors of congestive heart failure, hypertension, age, dia...

see more →

Drugs  15 results see all →

Clinicaltrials.gov  79 results

PVI Alone or in Combination wIth Substrate Modulation aFter electrIc Cardioversion Failure
https://clinicaltrials.gov/ct2/show/NCT05264831

May 6th, 2022 - Atrial fibrillation (AF) is the most common heart rhythm disorder. It is the result of uncoordinated action of the atrial myocardial cells, causing rapid and irregular contraction of the heart's atria. The AF prevalence in adults is currently esti...

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
https://clinicaltrials.gov/ct2/show/NCT05039359

Apr 28th, 2022 - This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled clinical study designed to evaluate the efficacy and safety of FlecIH-103 (flecainide acetate inhalation solution) compared with placebo in patients with recent-onset, sy...

Atrial Fibrillation After PFO Closure
https://clinicaltrials.gov/ct2/show/NCT04290052

Apr 14th, 2022 - This is a prospective, bicentric, observational cohort study which will be performed in University hospital center of Montpellier and Nîmes The study will include all consecutive patients, admitted for a percutaneous PFO closure after an ischemic ...

BTE and Pulsed Waveforms for Cardioversion of Atrial Fibrillation - Escalation Strategy and Manual Pressure
https://clinicaltrials.gov/ct2/show/NCT05316753

Apr 7th, 2022 - Background Commercially available defibrillators generate direct current (DC) shock with various waveforms using distinct technologies. These waveforms are suggested to have different efficacy and safety. Although the superiority of biphasic over ...

see more →

News  174 results

Global Gains in Heart Function From Early AF Rhythm Control
https://www.medscape.com/viewarticle/970329

Mar 15th, 2022 - The case for early rhythm control, achieved by ablation or cardioversion, in most patients with atrial fibrillation (AF) is mechanistically stronger with a new study suggesting the strategy can improve structural and functional heart damage from t...

Strategies for Managing Atrial Fibrillation in Patients on BTKi
https://www.onclive.com/view/strategies-for-managing-atrial-fibrillation-in-patients-on-btki

Oct 15th, 2021 - Farrukh Awan, MD: Atrial fibrillation [AFib] is the most common issue with these patients [with chronic lymphocytic leukemia]. Another thing I learned the hard way is that when patients without a history of AFib got on a BTK inhibitor, with a rapi...

A Cardiologist Shares Important Insights Into the Diagnosis and Treatment of Amyloidosis
https://www.onclive.com/view/a-cardiologist-shares-important-insights-into-the-diagnosis-and-treatment-of-amyloidosis

Oct 6th, 2021 - The 3 most common types of amyloidosis––TTR mutant, TTR wild-type, and amyloid light chain (AL)––have a significant amount of cardiac involvement, making cardiologists essential players in the diagnostic workup and treatment of these patients, exp...

Vaccine-Induced Myocarditis Concerns Demand Respect, Not Absolutism
https://www.medscape.com/viewarticle/954038

Jul 1st, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For the first half of 2021, the mRNA vaccines looked to be near perfect. The trials reported more than 90% efficacy for the Pfizer and Moderna vac...

New AHA Statement Urges Attention to Sleep Apnea
https://www.medscape.com/viewarticle/953527

Jun 22nd, 2021 - Obstructive sleep apnea (OSA) is common in patients with cardiovascular disease (CVD), yet it is often under-recognized and treated in cardiovascular practice, the American Heart Association (AHA) says in a new scientific statement. "Obstructive s...

see more →

Patient Education  5 results see all →